Andre Ruzycky

Dr. Ruzycky is a senior corporate development executive who has served in senior innovation leadership roles for several top global medical device and diagnostics companies. Most recently Dr. Ruzycky was Vice President, Strategy and Business Development for Becton Dickinson's Diagnostic Systems Group. Previously, he was VP Corporate Development for Hologic Inc., and Vice President, Technology Assessment at Johnson & Johnson’s Ortho Clinical Diagnostics Division.

Dr. Ruzycky earned a BS Degree (biochemistry) from McMaster University, a PhD in Pharmacology from the University of Buffalo, and a MBA form the University of Pittsburgh. He began his career in medical research with Research Fellowships at Harvard Medical School and at the University of California San Francisco, followed by a faculty appointment at the University of Pittsburgh School of Medicine. He brings extensive experience in novel IVD product development and investment with focus on cancer and infectious disease diagnostics and diagnostics platforms.